The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Cancer-Related Inflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 2×
“IL-10 is an immunosuppressive and anti-inflammatory cytokine also linked with inflammation-associated cancer [7].”
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1200 · Cited by 1,795
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 1×
“TNF-α has also been shown to contribute to tumor initiation by stimulation of genotoxic reactive nitrogen (RNS) and oxygen (ROS) species [39].”
Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity
Bloom, B. R., & Bennett, B. (1966) · Science · doi:10.1126/science.153.3731.80 · Cited by 1,603
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
DeNardo, D. G., Barreto, J. B., Andreu, P., Vasquez, L., Tawfik, D., Kolhatkar, N., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,353
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327 · cited 1×
“Colon Cancer [31]”
David, J. R. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.56.1.72 · Cited by 1,273
Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269
Gastric Cancer Originating from Bone Marrow-Derived Cells
Houghton, J., Stoicov, C., Nomura, S., Rogers, A. B., Carlson, J., Li, H., Cai, X., Fox, J. G., Goldenring, J. R., & Wang, T. C. (2004) · Science · doi:10.1126/science.1099513 · Cited by 1,170
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
MIF Signal Transduction Initiated by Binding to CD74
Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., & Bucala, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030286 · Cited by 1,154
MIF as a glucocorticoid-induced modulator of cytokine production
Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., & Bucala, R. (1995) · Nature · doi:10.1038/377068a0 · Cited by 1,149
Role of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 888
Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., & Glauser, M. P. (2000) · Nature Medicine · doi:10.1038/72262 · Cited by 723
CD44 Is the Signaling Component of the Macrophage Migration Inhibitory Factor-CD74 Receptor Complex
Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.020 · Cited by 677
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.
Bacher, M., Metz, C. N., Calandra, T., Mayer, K., Chesney, J., Lohoff, M., Gemsa, D., Donnelly, T., & Bucala, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7849 · Cited by 664
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1375 · Cited by 649 · cited 1×
“MIF also has the ability to protect tumor cells from apoptosis [77, 78].”
Balkwill, F., & Coussens, L. M. (2004) · Nature · doi:10.1038/431405a · Cited by 627
Gabitass, R. F., Annels, N. E., Stocken, D. D., Pandha, H. A., & Middleton, G. W. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1028-0 · Cited by 575
Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis
Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J., Harran, P., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 571
Korkaya, H., Kim, G.-I., Davis, A., Malik, F., Henry, N. L., Ithimakin, S., Quraishi, A. A., Tawakkol, N., D'Angelo, R., Paulson, A. K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.014 · Cited by 538
Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Swigart, L. B., & Evan, G. I. (2007) · Nature Medicine · doi:10.1038/nm1649 · Cited by 507
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK
Hagemann, T., Wilson, J., Kulbe, H., Li, N. F., Leinster, D. A., Charles, K., Klemm, F., Pukrop, T., Binder, C., & Balkwill, F. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1197 · Cited by 434
Self-citationTumor-induced immune dysfunction: the macrophage connection
Elgert, K. D., Alleva, D. G., & Mullins, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.275 · Cited by 426
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422
Endogenous IL-17 contributes to reduced tumor growth and metastasis
Kryczek, I., Wei, S., Szeliga, W., Vatan, L., & Zou, W. (2009) · Blood · doi:10.1182/blood-2008-09-177360 · Cited by 403
Interleukin-10 and the immune response against cancer: a counterpoint
Mocellin, S., Marincola, F. M., & Young, H. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705358 · Cited by 402
Kulbe, H., Thompson, R., Wilson, J. L., Robinson, S., Hagemann, T., Fatah, R., Gould, D., Ayhan, A., & Balkwill, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2941 · Cited by 386
Self-citationCoussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 384
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
Feldmann, M., & Maini, S. R. N. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00626.x · Cited by 381
The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
Charles, K. A., Kulbe, H., Soper, R., Escorcio-Correia, M., Lawrence, T., Schultheis, A., Chakravarty, P., Thompson, R. G., Kollias, G., Smyth, J. F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39065 · Cited by 338
Self-citationEpithelial cancer cell migration: a role for chemokine receptors?
Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., & Balkwill, F. R. (2001) · PubMed · Cited by 337
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
Borrello, M. G., Alberti, L., Fischer, A., Degl'Innocenti, D., Ferrario, C., Gariboldi, M., Marchesi, F., Allavena, P., Greco, A., Collini, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503039102 · Cited by 331
Yang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604008103 · Cited by 322
Tumor necrosis factor, cancer and anticancer therapy
MOCELLIN, S., ROSSI, C., PILATI, P., & NITTI, D. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.11.001 · Cited by 311
The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting
Fingerle-Rowson, G., Petrenko, O., Metz, C. N., Forsthuber, T. G., Mitchell, R., Huss, R., Moll, U., Müller, W., & Bucala, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533295100 · Cited by 284
Anti–Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
Egberts, J.-H., Cloosters, V., Noack, A., Schniewind, B., Thon, L., Klose, S., Kettler, B., von Forstner, C., Kneitz, C., Tepel, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5704 · Cited by 259
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Harrison, M. L., Obermueller, E., Maisey, N. R., Hoare, S., Edmonds, K., Li, N. F., Chao, D., Hall, K., Lee, C., Timotheadou, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2136 · Cited by 251
Maniati, E., Bossard, M., Cook, N., Candido, J. B., Emami-Shahri, N., Nedospasov, S. A., Balkwill, F. R., Tuveson, D. A., & Hagemann, T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45797 · Cited by 248
Self-citationMeyer-Siegler, K. L., Iczkowski, K. A., Leng, L., Bucala, R., & Vera, P. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8730 · Cited by 222
Simpson, K. D., Templeton, D. J., & Cross, J. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201161 · Cited by 214
Venkatakrishnan, G., Salgia, R., & Groopman, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6868 · Cited by 211
Bellone, G., Smirne, C., Mauri, F. A., Tonel, E., Carbone, A., Buffolino, A., Dughera, L., Robecchi, A., Pirisi, M., & Emanuelli, G. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0047-0 · Cited by 209
Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development
Arnott, C. H., Scott, K. A., Moore, R. J., Robinson, S. C., Thompson, R. G., & Balkwill, F. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207317 · Cited by 208
Madhusudan, S., Foster, M., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., Talbot, D. C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0730 · Cited by 205
Rao, V. P., Poutahidis, T., Ge, Z., Nambiar, P. R., Boussahmain, C., Wang, Y. Y., Horwitz, B. H., Fox, J. G., & Erdman, S. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0558 · Cited by 184
Brown, E. R., Charles, K. A., Hoare, S. A., Rye, R. L., Jodrell, D. I., Aird, R. E., Vora, R., Prabhakar, U., Nakada, M., Corringham, R. E., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn054 · Cited by 181
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
Verjans, E., Noetzel, E., Bektas, N., Schütz, A. K., Lue, H., Lennartz, B., Hartmann, A., Dahl, E., & Bernhagen, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-230 · Cited by 168
Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer
Madhusudan, S., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., & Ganesan, T. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.127 · Cited by 167
Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R., & Wilson, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0957 · Cited by 159
Self-citationSignalling and survival pathways in multiple myeloma
Bommert, K., Bargou, R. C., & Stühmer, T. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.12.026 · Cited by 158
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
Leech, M. T., Metz, C. N., Santos, L. L., Peng, T., Holdsworth, S. R., Bucala, R., & Morand, E. F. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199805)41:5<910::aid-art19>3.0.co;2-e · Cited by 158
Ogden, C. A., Pound, J. D., Batth, B. K., Owens, S., Johannessen, I., Wood, K., & Gregory, C. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3015 · Cited by 147
Macrophage Migration Inhibitory Factor Promotes Intestinal Tumorigenesis
Wilson, J. M., Coletta, P. L., Cuthbert, R. J., Scott, N. A., MacLennan, K., Hawcroft, G., Leng, L., Lubetsky, J. B., Jin, K. K., Lolis, E., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.061 · Cited by 147
Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brüstle, A., Weigmann, B., Atreya, R. N., Wirtz, S. J., Becker, C., Hoffman, A. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33227 · Cited by 143
Mechanisms and effectors of MIF-dependent promotion of tumourigenesis
Mitchell, R. A. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.07.002 · Cited by 142
Fujisawa, T., Joshi, B. H., & Puri, R. K. (2011) · International Journal of Cancer · doi:10.1002/ijc.26366 · Cited by 138
Zins, K., Abraham, D., Sioud, M., & Aharinejad, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2295 · Cited by 127
Tumor Necrosis Factor-α Promotes Malignant Pleural Effusion
Stathopoulos, G. T., Kollintza, A., Moschos, C., Psallidas, I., Sherrill, T. P., Pitsinos, E. N., Vassiliou, S., Karatza, M., Papiris, S. A., Graf, D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1064 · Cited by 120
Kitakata, H., Nemoto‐Sasaki, Y., Takahashi, Y., Kondo, T., Mai, M., & Mukaida, N. (2002) · PubMed · Cited by 118
The transcription factor NFATc2 controls IL-6–dependent T cell activation in experimental colitis
Weigmann, B., Lehr, H. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S. G., Schmidt, J., Galle, P. R., Rose‐John, S., & Neurath, M. F. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072484 · Cited by 114
Reinart, N., Nguyen, P., Bouças, J., Rosen, N., Kvasnicka, H. M., Heukamp, L. C., Rudolph, C., Ristovska, V., Velmans, T., Mueller, C., et al. (2012) · Blood · doi:10.1182/blood-2012-05-431452 · Cited by 109
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
Scotton, C. J., Milliken, D., Wilson, J. L., Raju, S., & Balkwill, F. R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2020 · Cited by 96
Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation
Bonecchi, R., Borroni, E. M., Anselmo, A., Doni, A., Savino, B., Mirolo, M., Fabbri, M., Jala, V. R., Haribabu, B., Mantovani, A., et al. (2008) · Blood · doi:10.1182/blood-2007-08-108316 · Cited by 96
Interleukin‐13 receptor α2 chain
Kioi, M., Kawakami, M., Shimamura, T., Husain, S. R., & Puri, R. K. (2006) · Cancer · doi:10.1002/cncr.22134 · Cited by 95
Howlett, M., Giraud, A. S., Lescesen, H., Jackson, C. B., Kalantzis, A., van Driel, I. R., Robb, L. G., der Hoek, M. B. V., Ernst, M., Minamoto, T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.003 · Cited by 93
Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.
Lech‐Marańda, E., Bienvenu, J., Michallet, A., Houot, R., Robak, T., Coiffier, B., & Salles, G. (2006) · PubMed · Cited by 84
Galbán, S., Fan, J., Martindale, J. L., Cheadle, C., Hoffman, B. E., Woods, M. P., Temeles, G. L., Brieger, J., Decker, J., & Gorospe, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2316-2328.2003 · Cited by 81
Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer
Hanavadi, S., Martin, T. A., Watkins, G., Mansel, R. E., & Jiang, W. G. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.028 · Cited by 75
Screpanti, I., Musiani, P., Bellavia, D., Cappelletti, M., Aiello, F. B., Maroder, M., Frati, L., Modesti, A., Gulino, A., & Poli, V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1561 · Cited by 69
Kawakami, M., Kawakami, K., Kasperbauer, J. L., Hinkley, L., Tsukuda, M., Strome, S. E., & Puri, R. K. (2003) · PubMed · Cited by 54
Lawrence, T., Hagemann, T., & Balkwill, F. R. (2007) · Science · doi:10.1126/science.1146052 · Cited by 48
Self-citationSpontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55
Tomita, Y., Yang, X., Ishida, Y., Nemoto‐Sasaki, Y., Kondo, T., Oda, M., Watanabe, G., Chaldakov, G. N., Fujii, C., & Mukaida, N. (2004) · International Journal of Cancer · doi:10.1002/ijc.20493 · Cited by 41
Michels, C., Scales, H. E., Saunders, K. A., McGowan, S. J., Brombracher, F., Alexander, J. K., & Lawrence, C. E. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02987.x · Cited by 16
Immunology for the next generation
Balkwill, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1628 · Cited by 10
Cited by
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 539
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 513
The Inflammatory Chemokine CCL5 and Cancer Progression
Aldinucci, D., & Colombatti, A. (2014) · Mediators of Inflammation · doi:10.1155/2014/292376 · Cited by 438
Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Tilg, H., Byrne, C. D., & Targher, G. (2022) · Gut · doi:10.1136/gutjnl-2021-324191 · Cited by 363
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer
Liu, X., Wu, S., Yang, Y., Zhao, M., Zhu, G., & Hou, Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.003 · Cited by 348
Metadata
- Authors
- Candido, J., & Hagemann, T.
- Venue
- Journal of Clinical Immunology
- Published
- 2012-12-09
- Volume
- 33
- Issue
- S1
- Pages
- 79-84
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W2087448306
- Cited by
- 653
- References
- 86
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.